Additional information
Grey Powder
59654-17-0
ACI-025603
218.2-221.4°C
C9H18N2O2S.2HBr
380.14
Ambient
2-8°C
Prostaglandin
Pharmaceutical Impurity Standards
5-[(2S,3S,4R)-3,4-diaminothiolan-2-yl]pentanoic acid dihydrobromide
5-[(2S,3S,4R)-3,4-Diaminothiolan-2-yl]pentanoic acid
2-Thiophenepentanoic acid, 3,4-diaminotetrahydro-, dihydrobromide, (2S,3S,4R)





![N-BOC-N-DESHYDROXYETHYL DASATINIB (25 mg) (2-Methyl-2-propanyl 4-[6-({5-[(2-chloro-6-methylphenyl)carbamoyl]-1,3-thiazol-2-yl}amino)-2-methyl-4-pyrimidinyl]-1-piperazinecarboxylate )](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)